ZENITHDRUGPharmaceuticals
ZENITH DRUGS LIMIT — PE Ratio & Valuation Analysis
₹41.00
+0.00%
Current P/E20.98xPrice to earnings
Industry P/E31.77xSector average
✅
34.0% Discount to Industry
ZENITHDRUG P/E 20.98x vs sector avg 31.77x
💡
Understanding ZENITH DRUGS LIMIT Valuation
ZENITH DRUGS LIMIT (ZENITHDRUG) currently trades at 20.98x earnings. The Pharmaceuticals sector average PE is 31.77x. ZENITHDRUG is trading at a discount to peers — may indicate relative value. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.11%
Dividend Yield
0.00%
More on ZENITH DRUGS LIMIT
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.